Last reviewed · How we verify

NCT05422040

Dry Needlig Vesus Tecartherapy in Low-back Pain Treatment

Recruiting now NA Last updated 16 October 2024
What this trial tests

NA trial testing Dry needling in Low Back Pain in 60 participants. Currently enrolling.

Timeline
20 June 2022
Primary endpoint
1 September 2025
1 September 2025

Quick facts

Lead sponsorUniversity of Alcala
PhaseNA
StatusRecruiting now
Study typeINTERVENTIONAL
Allocationrandomized
Designparallel
Maskingdouble
Primary purposetreatment
Enrollment60
Start date20 June 2022
Primary completion1 September 2025
Estimated completion1 September 2025
Sites1 location across Spain

Drugs / interventions tested

Conditions studied

Sponsor

University of Alcala

Who can join

Adults 18 to 65, any sex, with Low Back Pain. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Introduction: Diathermy is a new tool that could help subjects with chronic low back pain (CLBP), with no studies having compared it to other interventions already investigated such as dry needling. Hypothesis: Diathermy is more effective than dry needling in improving pain intensity in the short term in subjects with CLBP. Design: randomised controlled trial Methods: We will conduct a convenience sampling, with subjects receiving 2 treatment sessions with diathermy or dry needling, according to allocation. Subjects will be assessed at baseline, 1 week, 1 month and 3 months after treatment for pain intensity, disability, kinesiophobia and catastrophizing. Analysis of variance (ANOVA) and moderation analysis will be performed to evaluate the results, with 95% confidence intervals (CI).

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other trials of Dry needling

Trials testing the same drug.

Other recruiting trials for Low Back Pain

Currently open trials in the same condition.

Other University of Alcala trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05422040.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing